Cargando…

CM082 Enhances the Efficacy of Chemotherapeutic Drugs by Inhibiting the Drug Efflux Function of ABCG2

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Xu, Lejia, Huang, Jiwei, Liu, Jie, Xi, Yun, Zheng, Zongheng, To, Kenneth K.W., Chen, Zhen, Wang, Fang, Zhang, Yongming, Fu, Liwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679938/ https://www.ncbi.nlm.nih.gov/pubmed/38020061 http://dx.doi.org/10.1016/j.omto.2023.100746

Ejemplares similares

CM082 Enhances the Efficacy of Chemotherapeutic Drugs by Inhibiting the Drug Efflux Function of ABCG2
por: Xu, Lejia, et al.
Publicado: (2019)

Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo
por: Guo, Xiaoran, et al.
Publicado: (2018)

Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo
por: Zeng, Fanpu, et al.
Publicado: (2020)

Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo
por: Fan, Yingfang, et al.
Publicado: (2022)

Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo
por: Hu, Jing, et al.
Publicado: (2015)

KD025, an anti-adipocyte differentiation drug, enhances the efficacy of conventional chemotherapeutic drugs in ABCG2-overexpressing leukemia cells
por: Jing, Wen, et al.
Publicado: (2020)

The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats
por: Ren, Chengda, et al.
Publicado: (2017)

SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2
por: Sun, R, et al.
Publicado: (2015)

Correction: Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
Publicado: (2014)

Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo
por: Yang, Ke, et al.
Publicado: (2020)

Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs
por: Wu, Chung-Pu, et al.
Publicado: (2020)

GSK2606414 Sensitizes ABCG2-Overexpressing Multidrug-Resistant Colorectal Cancer Cells to Chemotherapeutic Drugs
por: Yu, Ze-Zhong, et al.
Publicado: (2023)

Author Correction: ABCG2-overexpressing H460/MX20 cell xenografts in athymic nude mice maintained original biochemical and cytological characteristics
por: Zhang, Wei, et al.
Publicado: (2020)

Celecoxib Up Regulates the Expression of Drug Efflux Transporter ABCG2 in Breast Cancer Cell Lines
por: Kalalinia, Fatemeh, et al.
Publicado: (2014)

Rheumatoid Arthritis Disease Activity Is Determinant for ABCB1 and ABCG2 Drug-Efflux Transporters Function
por: Atisha-Fregoso, Yemil, et al.
Publicado: (2016)

The Novel benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter
por: Narayanan, Silpa, et al.
Publicado: (2021)

Correction: Modulating Drug Resistance by Targeting BCRP/ABCG2 Using Retrovirus-Mediated RNA Interference
Publicado: (2014)

Molecular basis of cholesterol efflux via ABCG subfamily transporters
por: Sun, Yingyuan, et al.
Publicado: (2021)

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
por: Wu, Shaocong, et al.
Publicado: (2018)

Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinoma
por: Sheng, Xinan, et al.
Publicado: (2020)

Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance
por: Wang, Xiaokun, et al.
Publicado: (2019)

Local bacteria affect the efficacy of chemotherapeutic drugs
por: Lehouritis, Panos, et al.
Publicado: (2015)

Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer
por: Dong, Yang, et al.
Publicado: (2019)

Correction to: Binding mechanism of anti-cancer chemotherapeutic drug mitoxantrone to DNA characterized by magnetic tweezers
por: Kreft, Dennis, et al.
Publicado: (2019)

AhR-activating pesticides increase the bovine ABCG2 efflux activity in MDCKII-bABCG2 cells
por: Kuhnert, Lydia, et al.
Publicado: (2020)

Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrier
por: Kumar, Jeyan S., et al.
Publicado: (2016)

RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes
por: Daffu, Gurdip, et al.
Publicado: (2015)

The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response
por: Luo, Min, et al.
Publicado: (2016)

Correction: Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs
por: Liu, Wei, et al.
Publicado: (2022)

Status of FPP Project D-082
por: Allardyce, B W
Publicado: (1994)

Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer
por: Chen, Jihui, et al.
Publicado: (2021)

The influence of ABCG2 polymorphism on erlotinib efflux in the K562 cell line
por: Svedberg, Anna, et al.
Publicado: (2020)

Structural basis for abscisic acid efflux mediated by ABCG25 in Arabidopsis thaliana
por: Ying, Wei, et al.
Publicado: (2023)

WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells
por: Zhang, Hui, et al.
Publicado: (2014)

SR-BI associates with ABCG1 and inhibits ABCG1-mediated cholesterol efflux from cells to high-density lipoprotein 3
por: Song, Guohua, et al.
Publicado: (2012)

Title unknown, CERN-ALEPH-99-082
por: CERN. Geneva. ALEPH
Publicado: (1999)

MON-082 The Neonatal Screen That Cried Wolff
por: D’Ambrosio, Fabiola, et al.
Publicado: (2020)

Coix Seed Extract Enhances the Anti-Pancreatic Cancer Efficacy of Gemcitabine through Regulating ABCB1- and ABCG2-Mediated Drug Efflux: A Bioluminescent Pharmacokinetic and Pharmacodynamic Study
por: Qian, Yifan, et al.
Publicado: (2019)

Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux
por: Sankaranarayanan, Sandhya, et al.
Publicado: (2009)

Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines
por: Galetti, Maricla, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lgq6nak2k2kdqga2udvp09spua